Literature DB >> 23354944

Review article: risks of anemia and related management strategies: can perioperative blood management improve patient safety?

Gregory M T Hare1, John Freedman, C David Mazer.   

Abstract

PURPOSE: Anemia in both acute and chronic conditions is associated with an increased risk of organ injury (brain, heart, kidney) and mortality. Thus, anemia is not "safe". Impairment of tissue oxygen delivery likely contributes as a central mechanism; however, the existing treatments for anemia (i.e., transfusion, erythropoiesis stimulating agents, blood substitutes) have not produced a demonstrable improvement in patient outcomes despite their efficacy to increase blood oxygen content. Indeed, transfusion of red blood cells (RBCs) has been attributed to increase mortality in non-bleeding patients. Thus, the pathophysiology of anemia-induced morbidity and mortality and its treatments are complex and incompletely understood. New knowledge continues to emerge regarding the cellular mechanisms that maintain oxygen homeostasis during anemia. Nevertheless, the application of this knowledge has not yet led to improvements in patient outcomes. As both anemia and transfusion are associated with increased mortality, utilization of multimodal patient blood management strategies may be effective in avoiding both of these predictors of adverse outcomes. We propose to review new strategies to avoid both anemia and transfusion with the goal of improving patient outcomes and safety. PRINCIPAL
FINDINGS: We reviewed several approaches that utilize patient blood management to improve patient outcomes, including 1) characterization of biomarkers of anemia-induced tissue hypoxia to identify appropriate patient-specific treatment thresholds or hemoglobin (Hb) triggers; 2) development of adequately powered clinical trials that will help to define appropriate guidelines for the perioperative treatment of anemia and optimal Hb thresholds for transfusion of RBCs in specific patient populations; and 3) demonstration that an established blood conservation program (ONTraC) can reduce RBC transfusion and its associated adverse outcomes.
CONCLUSIONS: Anemia is associated with increased morbidity and mortality. Ongoing initiatives to treat anemia and optimize patient blood management may improve patient outcomes. A broader application of these approaches may improve the overall safety of anesthesia and surgery for patients with anemia.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23354944     DOI: 10.1007/s12630-012-9861-y

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  18 in total

1.  Restrictive versus liberal red blood cell transfusion for cardiac surgery: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Babikir Kheiri; Ahmed Abdalla; Mohammed Osman; Tarek Haykal; Sai Chintalapati; James Cranford; Jason Sotzen; Meghan Gwinn; Sahar Ahmed; Mustafa Hassan; Ghassan Bachuwa; Deepak L Bhatt
Journal:  J Thromb Thrombolysis       Date:  2019-02       Impact factor: 2.300

2.  Association between hypoxemia and anemia following arthroplasty: A pilot clinical study.

Authors:  Fuqiang Gao; Wei Sun; Wanshou Guo; Liming Cheng; Zirong Li; Nepali Kush
Journal:  Exp Ther Med       Date:  2016-02-26       Impact factor: 2.447

Review 3.  Economic impact of blood transfusions: balancing cost and benefits.

Authors:  Tufan Oge; Cemil Hakan Kilic; Gokhan Sami Kilic
Journal:  Eurasian J Med       Date:  2014-02

4.  Blood Transfusions Correct Anemia and Improve Tissue Oxygenation in Surgical and Critically ill Patients.

Authors:  Can İnce
Journal:  Turk J Anaesthesiol Reanim       Date:  2017-02-01

5.  Restrictive compared with liberal red cell transfusion strategies in cardiac surgery: a meta-analysis.

Authors:  Nadine Shehata; Nikhil Mistry; Bruno R da Costa; Tiago V Pereira; Richard Whitlock; Gerard F Curley; David A Scott; Gregory M T Hare; Peter Jüni; C David Mazer
Journal:  Eur Heart J       Date:  2019-04-01       Impact factor: 29.983

6.  Non-Parametric Combined Reference Regions and Prediction of Clinical Risk.

Authors:  Roy Malka; Carlo Brugnara; Ron Cialic; John M Higgins
Journal:  Clin Chem       Date:  2020-02-01       Impact factor: 8.327

7.  Tranexamic acid administration to older patients undergoing primary total hip arthroplasty conserves hemoglobin and reduces blood loss.

Authors:  Hossam El Beheiry; Ashley Lubberdink; Nigel Clements; Kiran Dihllon; Vicky Sharma
Journal:  Can J Surg       Date:  2018-06       Impact factor: 2.089

8.  Ultrasonographic Assessment of the Distal Femoral Cartilage Thickness in Patients with Homozygous Sickle Cell Disease.

Authors:  Mustafa Turgut Yildizgoren; Mehmet Rami Helvaci; Nilgun Ustun; Kasim Osmanoglu; Ayse Dicle Turhanoglu
Journal:  Cartilage       Date:  2015-11-06       Impact factor: 4.634

9.  Risk factors and birth outcomes of anaemia in early pregnancy in a nulliparous cohort.

Authors:  Gwinyai Masukume; Ali S Khashan; Louise C Kenny; Philip N Baker; Gill Nelson
Journal:  PLoS One       Date:  2015-04-15       Impact factor: 3.240

Review 10.  When to transfuse your acute care patient? A narrative review of the risk of anemia and red blood cell transfusion based on clinical trial outcomes.

Authors:  Gregory M T Hare; Melina P Cazorla-Bak; S F Michelle Ku; Kyle Chin; Nikhil Mistry; Michael C Sklar; Katerina Pavenski; Ahmad Alli; Adriaan Van Rensburg; Jan O Friedrich; Andrew J Baker; C David Mazer
Journal:  Can J Anaesth       Date:  2020-08-07       Impact factor: 6.713

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.